Please provide your email address to receive an email when new articles are posted on . INDIANAPOLIS — The guidelines for restless legs syndrome treatment no longer indicate dopamine agonists as a ...

Large Korean cohort study reveals a link between restless legs syndrome and Parkinson’s disease, highlighting opportunities for early detection and potential prevention Restless legs syndrome (RLS) is ...

Restless legs syndrome (RLS) is a chronic, usually idiopathic disorder characterized by uncontrollable urges to move the legs or arms at night along with unpleasant sensations in the affected limbs.

Parkinson's risk appeared to be higher in people with restless legs syndrome in a Korean study. Dopamine agonist treatment was tied to less Parkinson's risk in patients with restless legs syndrome.

Restless legs syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological condition that affects about 7% of people. Each person's condition is categorized as mild, moderate, severe or very ...

Add Yahoo as a preferred source to see more of our stories on Google. For some, restless legs syndrome can be so severe that they can’t sleep. (Getty Images) (AndreyPopov via Getty Images) Up to 10% ...

This study demonstrates that the majority of patients with RLS at Community Medical Centers were receiving levodopa rather than FDA-approved dopamine agonists. Chronic use of levodopa could lead to ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behavior or pathological gambling—not so common. But a BBC investigation has highlighted that ...

NEW YORK (Reuters Health) - The impulsive behavior that sometimes develops as a side effect of treatment with "dopamine agonists" drugs may not be limited just to patients with Parkinson's disease.

Up to 10% of Americans suffer from restless legs syndrome (RLS), a neurological disorder that causes uncomfortable sensations in the legs and an irresistible urge to move them. But despite how common ...